Navigation Links
Biodel to Present at Upcoming Conferences
Date:9/24/2010

DANBURY, Conn., Sept. 24 /PRNewswire-FirstCall/ -- Biodel Inc. (Nasdaq: BIOD) announced today that it will be presenting at the following upcoming conferences:

  • Fifth Annual JMP Securities Healthcare Conference, September 28, 2010 at 12:00 pm Eastern time at the New York Palace in New York, NY.   Interested parties can access a link to the live webcast of the presentation from the News & Events section of the Biodel website www.biodel.com. Replays of the presentation will be available for 90 days.
  • Cantor Catalyst Conference, September 29, 2010 at 3:00 pm Eastern time at the Le Parker Meridien in New York, NY.

About Biodel Inc.

Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes.  Biodel's product candidates are developed using VIAdel™ technology, which reformulates existing FDA-approved peptide drugs.  Biodel's new drug application for its most advanced product candidate, Linjeta™, has been accepted for review by the FDA with a Prescription Drug User Fee Act action date of October 30, 2010.  Earlier-stage product candidates include VIAtab™, a sublingual tablet formulation of insulin, a line of basal insulins, and a stabilized formulation of glucagon.  For further information regarding Biodel, please visit the company's website at www.biodel.com.

BIOD-G

CONTACT: Seth Lewis, +1-646-378-2952


'/>"/>
SOURCE Biodel Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
2. Biodel Inc. Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject(TM) and Plans Manufacturing Facility for VIAject(TM)
3. Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
4. Biodel Announces Schedule for Presentations at the 37th Annual Meeting and Exposition of the Controlled Release Society
5. Biodel to Raise $9.4 Million Through Registered Direct Offering
6. Biodel Appoints Arthur Urciuoli to its Board of Directors
7. Biodel Reports Research Progress in Poster Session on Short-Acting Insulins at 46th EASD Annual Meeting
8. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
9. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
10. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
11. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... , Nov. 28, 2014 Aratana Therapeutics, ... focused on the licensing or acquisition, development and commercialization ... companion animals, today announced that it will present at ... to be held December 2-3, 2014, at the New ... . Steven St. Peter , M.D., ...
(Date:11/28/2014)... 2014 Chinese magnesium alloy maker DongGuan Eontec ... magnesium alloy bone fixation screw has received Chinese regulatory ... and instrument and that the company acknowledges receipt of ... Science and Technology Daily journalists Wang Xiangming ... and founder, Professor Li Yangde , has been ...
(Date:11/27/2014)... 2014 Hovione announced today it ... with the U.S. Food and Drug Administration (FDA). This ... improved drug delivery options for established drugs. ... formulation using a new patented crystalline base form of ... prescribed oral antibiotics for acne. Currently, there are no ...
Breaking Medicine Technology:Aratana Therapeutics to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Chinese magnesium alloy manufacturer Eontec expects to have its medical magnesium alloy available for clinical trial in 2015 2Chinese magnesium alloy manufacturer Eontec expects to have its medical magnesium alloy available for clinical trial in 2015 3Chinese magnesium alloy manufacturer Eontec expects to have its medical magnesium alloy available for clinical trial in 2015 4Hovione Files its First Investigational New Drug Application With the FDA 2
... in a row, A dvertising ... www.eveo.com ) as the #1 Independent Digital Healthcare Agency in the ... d A ge rankings, ... (Photo:   http://photos.prnewswire.com/prnh/20110516/SF03150 ) (Logo:   http://photos.prnewswire.com/prnh/20100630/SF29260LOGO-a ...
... enhanced the capability of its GlideScope® Cobalt AVL video ... designed for small children.  The new Stat is a ... patents weighing from 10 to 28 kilograms, extending the ... kilograms) through patients weighing up to 28 kilograms. ...
Cached Medicine Technology:Eveo Ranked #1 Independent Digital Healthcare Agency in U.S. 2nd Year in a Row 2Verathon Extends Range of GlideScope Video Laryngoscope With New Single Use - GVL 2.5 Stat for Small Children 2
(Date:11/28/2014)... 2014 Mirena lawsuits ( http://www.mirenalawsuit2014.com/ ... New Jersey’s Bergen County Superior Court, where the ... there is quickly approaching 1,300, Bernstein Liebhard LLP ... shows 1,293 lawsuits now pending in the consolidated ... complications resulting from spontaneous migration of the birth ...
(Date:11/28/2014)... 28, 2014 Miami's Plastic Surgery of ... Practice founder Dr. Jeffrey Epstein is excited ... a groundbreaking WordPress platform, the site is uniquely designed ... Currently, up to 75% of all prospective rhinoplasty patients ... people are logging on with smartphones, tablets, and laptops, ...
(Date:11/28/2014)... 2014 Secura Consultants, based in ... marketing organizations in the country focused on delivering ... marketplace. Secura Consultants is proud to offer complimentary ... Group, a leading global financial company. , Many ... the ownership interest comes the need for business ...
(Date:11/28/2014)... -- Planning on seconds at Thanksgiving Day dinner this ... as gastroesophageal reflux disease (GERD) -- a few steps may ... nose and throat specialist at Lenox Hill Hospital in New ... on Thanksgiving: Pace yourself. Rather than ... throughout the day. It,s also a good idea to have ...
(Date:11/28/2014)... Texas (PRWEB) November 28, 2014 ... prediabetes testing and treatment, helped employees learn their ... on-site diabetes blood screening at a local school ... Diabetes @ Work initiative. , As the ... Work program , PreDiabetes Centers is co-hosting diabetes-prevention ...
Breaking Medicine News(10 mins):Health News:Nearly 1,300 Mirena Lawsuits Now Filed in Consolidated New Jersey Litigation, Bernstein Liebhard LLP Reports 2Health News:Nearly 1,300 Mirena Lawsuits Now Filed in Consolidated New Jersey Litigation, Bernstein Liebhard LLP Reports 3Health News:Top Rhinoplasty Surgeon Launches Innovative Website 2Health News:Secura Consultants Offers Complimentary Buy-Sell Agreement Reviews 2Health News:Don't Let Chronic Heartburn Spoil Your Thanksgiving Feast 2Health News:PreDiabetes Centers Offers Workplace Diabetes Screening at Local School 2
... MECHANICSBURG, Pa., Nov. 12 Select Medical Corporation,("Select") ... Inc. ("CORA"),have mutually agreed to terminate the Agreement ... on October 1, 2007, pursuant to which Select ... Medical Corporation is a leading operator of specialty ...
... biologists at Jeffersons Kimmel Cancer Center in Philadelphia ... some potentially dangerous autoinflammatory diseases. In doing so, ... of the disease process, but have also identified ... arthritis to cancer. , Reporting in the journal ...
... 13, 8:00 EST -, SOUTH SAN FRANCISCO, ... a biopharmaceutical company, and Raven,biotechnologies, inc., a privately ... therapeutics (MAbs) for treating cancer, announced,today that their ... merger agreement. The merger is expected to create ...
... 12 Northwestern University,announced today that it ... study for women with locally recurrent or ... the efficacy of Nexavar(R),(sorafenib) tablets in combination ... cancer. Nexavar, an oral multi kinase inhibitor ...
... Letters to HHS Office of Inspector General and,Congressman ... Today, the American,Association for Homecare vigorously disputed the ... a basis for setting reimbursement rates for,power wheelchairs ... The Association outlined its concerns in letters sent ...
... found , MONDAY, Nov. 12 (HealthDay News) -- Correcting ... of life, it may lower risks for depression, U.S. ... Alabama at Birmingham studied 78 nursing home residents, 55 ... an eye exam and 64 residents who received eyeglasses ...
Cached Medicine News:Health News:Jefferson scientists uncover key pathway, potential drug targets in autoinflammatory disease 2Health News:VaxGen and Raven biotechnologies Announce Signing of Definitive Merger Agreement 2Health News:VaxGen and Raven biotechnologies Announce Signing of Definitive Merger Agreement 3Health News:VaxGen and Raven biotechnologies Announce Signing of Definitive Merger Agreement 4Health News:VaxGen and Raven biotechnologies Announce Signing of Definitive Merger Agreement 5Health News:VaxGen and Raven biotechnologies Announce Signing of Definitive Merger Agreement 6Health News:Northwestern University and ACORN Commence National Enrollment for Metastatic Breast Cancer Study 2Health News:Northwestern University and ACORN Commence National Enrollment for Metastatic Breast Cancer Study 3Health News:American Association for Homecare Disputes Validity of Internet Power Wheelchair Prices as Basis for Reimbursement of Services in Medicare 2Health News:American Association for Homecare Disputes Validity of Internet Power Wheelchair Prices as Basis for Reimbursement of Services in Medicare 3Health News: Eyeglasses Upgrade Helps Elderly Battle Depression 2
Stab incision blades color coded for simple and accurate identification...
Smooth, round edges allow for safe manipulation within the eye. 1.1mm wide gradually tapers to .50 mm wide. 45, 1.1mm wide, gradually tapers to .50mm wide....
... has two perforations which enable ... various single or bilateral configurations ... drape has two perforations which ... to various single or bilateral ...
30, 6.0mm from end...
Medicine Products: